Citadel Advisors - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2018$23,793,000
-13.4%
24,000,000
-7.7%
0.01%
-23.5%
Q4 2017$27,464,000
-15.0%
26,000,000
-14.8%
0.02%
-32.0%
Q3 2017$32,323,000
+41.7%
30,500,000
+41.9%
0.02%
+31.6%
Q2 2017$22,817,000
+137.6%
21,500,000
+115.9%
0.02%
+111.1%
Q1 2017$9,603,000
-73.3%
9,957,000
-71.9%
0.01%
-75.0%
Q4 2016$36,003,000
+175.4%
35,457,000
+153.3%
0.04%
+176.9%
Q3 2016$13,075,000
-64.3%
14,000,000
-72.8%
0.01%
-68.3%
Q2 2016$36,662,000
-30.1%
51,500,000
-10.4%
0.04%
-37.9%
Q1 2016$52,449,000
+4.5%
57,500,000
+29.2%
0.07%
+20.0%
Q4 2015$50,179,00044,500,0000.06%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q1 2017.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders